Pharmaceutical products
Original title: Open-House-Originale-Rabattverträge 2026-14 Crizotinib
| Country | Germany |
|---|---|
| Deadline | 2028-11-30 (740 days left) |
| Published | 2026-10-08 |
| Sectors | Health & life sciences |
| Source | TED - Tenders Electronic Daily (EU) |
Summary
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Crizotinib im Rahmen eines Open-House-Verfahrens.
The buyer, the value, the full description and the link to the official notice are available with a free account.